Global Pharmaceutical Products and CMO Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Pharmaceutical Products and CMO Industry Forecast” looks at past sales and reviews total world Pharmaceutical Products and CMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Products and CMO sales for 2023 through 2029. With Pharmaceutical Products and CMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Products and CMO industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Products and CMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Products and CMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Products and CMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Products and CMO and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Products and CMO.
The global Pharmaceutical Products and CMO market size is projected to grow from US$ 145080 million in 2022 to US$ 211010 million in 2029; it is expected to grow at a CAGR of 5.5% from 2023 to 2029.
United States market for Pharmaceutical Products and CMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pharmaceutical Products and CMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pharmaceutical Products and CMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pharmaceutical Products and CMO players cover Catalent, DPx, Lonza, Piramal Healthcare, Aenova, Jubilant, Famar, Boehringer Ingelheim and Fareva Holding, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Products and CMO market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Pharmaceutical Products and CMO Industry Forecast” looks at past sales and reviews total world Pharmaceutical Products and CMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Products and CMO sales for 2023 through 2029. With Pharmaceutical Products and CMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Products and CMO industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Products and CMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Products and CMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Products and CMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Products and CMO and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Products and CMO.
The global Pharmaceutical Products and CMO market size is projected to grow from US$ 145080 million in 2022 to US$ 211010 million in 2029; it is expected to grow at a CAGR of 5.5% from 2023 to 2029.
United States market for Pharmaceutical Products and CMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pharmaceutical Products and CMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pharmaceutical Products and CMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pharmaceutical Products and CMO players cover Catalent, DPx, Lonza, Piramal Healthcare, Aenova, Jubilant, Famar, Boehringer Ingelheim and Fareva Holding, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Products and CMO market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Active Pharmaceutical Ingredient (API)
- Finished Dosage Form (FDF)
- Pharmaceutical Packaging
- Specialty/Midsize
- Generics
- Big Pharma
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Catalent
- DPx
- Lonza
- Piramal Healthcare
- Aenova
- Jubilant
- Famar
- Boehringer Ingelheim
- Fareva Holding
- AbbVie
- Nipro Corp
- Vetter
- Sopharma
- Mylan (DPT Laboratories)
- Recipharm
- NextPharma Technologies
- Dishman
- Aesica
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical Products and CMO Market Size 2018-2029
2.1.2 Pharmaceutical Products and CMO Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Pharmaceutical Products and CMO Segment by Type
2.2.1 Active Pharmaceutical Ingredient (API)
2.2.2 Finished Dosage Form (FDF)
2.2.3 Pharmaceutical Packaging
2.3 Pharmaceutical Products and CMO Market Size by Type
2.3.1 Pharmaceutical Products and CMO Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Pharmaceutical Products and CMO Market Size Market Share by Type (2018-2023)
2.4 Pharmaceutical Products and CMO Segment by Application
2.4.1 Specialty/Midsize
2.4.2 Generics
2.4.3 Big Pharma
2.4.4 Others
2.5 Pharmaceutical Products and CMO Market Size by Application
2.5.1 Pharmaceutical Products and CMO Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Pharmaceutical Products and CMO Market Size Market Share by Application (2018-2023)
3 PHARMACEUTICAL PRODUCTS AND CMO MARKET SIZE BY PLAYER
3.1 Pharmaceutical Products and CMO Market Size Market Share by Players
3.1.1 Global Pharmaceutical Products and CMO Revenue by Players (2018-2023)
3.1.2 Global Pharmaceutical Products and CMO Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical Products and CMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL PRODUCTS AND CMO BY REGIONS
4.1 Pharmaceutical Products and CMO Market Size by Regions (2018-2023)
4.2 Americas Pharmaceutical Products and CMO Market Size Growth (2018-2023)
4.3 APAC Pharmaceutical Products and CMO Market Size Growth (2018-2023)
4.4 Europe Pharmaceutical Products and CMO Market Size Growth (2018-2023)
4.5 Middle East & Africa Pharmaceutical Products and CMO Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Pharmaceutical Products and CMO Market Size by Country (2018-2023)
5.2 Americas Pharmaceutical Products and CMO Market Size by Type (2018-2023)
5.3 Americas Pharmaceutical Products and CMO Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Products and CMO Market Size by Region (2018-2023)
6.2 APAC Pharmaceutical Products and CMO Market Size by Type (2018-2023)
6.3 APAC Pharmaceutical Products and CMO Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmaceutical Products and CMO by Country (2018-2023)
7.2 Europe Pharmaceutical Products and CMO Market Size by Type (2018-2023)
7.3 Europe Pharmaceutical Products and CMO Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical Products and CMO by Region (2018-2023)
8.2 Middle East & Africa Pharmaceutical Products and CMO Market Size by Type (2018-2023)
8.3 Middle East & Africa Pharmaceutical Products and CMO Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACEUTICAL PRODUCTS AND CMO MARKET FORECAST
10.1 Global Pharmaceutical Products and CMO Forecast by Regions (2024-2029)
10.1.1 Global Pharmaceutical Products and CMO Forecast by Regions (2024-2029)
10.1.2 Americas Pharmaceutical Products and CMO Forecast
10.1.3 APAC Pharmaceutical Products and CMO Forecast
10.1.4 Europe Pharmaceutical Products and CMO Forecast
10.1.5 Middle East & Africa Pharmaceutical Products and CMO Forecast
10.2 Americas Pharmaceutical Products and CMO Forecast by Country (2024-2029)
10.2.1 United States Pharmaceutical Products and CMO Market Forecast
10.2.2 Canada Pharmaceutical Products and CMO Market Forecast
10.2.3 Mexico Pharmaceutical Products and CMO Market Forecast
10.2.4 Brazil Pharmaceutical Products and CMO Market Forecast
10.3 APAC Pharmaceutical Products and CMO Forecast by Region (2024-2029)
10.3.1 China Pharmaceutical Products and CMO Market Forecast
10.3.2 Japan Pharmaceutical Products and CMO Market Forecast
10.3.3 Korea Pharmaceutical Products and CMO Market Forecast
10.3.4 Southeast Asia Pharmaceutical Products and CMO Market Forecast
10.3.5 India Pharmaceutical Products and CMO Market Forecast
10.3.6 Australia Pharmaceutical Products and CMO Market Forecast
10.4 Europe Pharmaceutical Products and CMO Forecast by Country (2024-2029)
10.4.1 Germany Pharmaceutical Products and CMO Market Forecast
10.4.2 France Pharmaceutical Products and CMO Market Forecast
10.4.3 UK Pharmaceutical Products and CMO Market Forecast
10.4.4 Italy Pharmaceutical Products and CMO Market Forecast
10.4.5 Russia Pharmaceutical Products and CMO Market Forecast
10.5 Middle East & Africa Pharmaceutical Products and CMO Forecast by Region (2024-2029)
10.5.1 Egypt Pharmaceutical Products and CMO Market Forecast
10.5.2 South Africa Pharmaceutical Products and CMO Market Forecast
10.5.3 Israel Pharmaceutical Products and CMO Market Forecast
10.5.4 Turkey Pharmaceutical Products and CMO Market Forecast
10.5.5 GCC Countries Pharmaceutical Products and CMO Market Forecast
10.6 Global Pharmaceutical Products and CMO Forecast by Type (2024-2029)
10.7 Global Pharmaceutical Products and CMO Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Catalent
11.1.1 Catalent Company Information
11.1.2 Catalent Pharmaceutical Products and CMO Product Offered
11.1.3 Catalent Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Catalent Main Business Overview
11.1.5 Catalent Latest Developments
11.2 DPx
11.2.1 DPx Company Information
11.2.2 DPx Pharmaceutical Products and CMO Product Offered
11.2.3 DPx Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 DPx Main Business Overview
11.2.5 DPx Latest Developments
11.3 Lonza
11.3.1 Lonza Company Information
11.3.2 Lonza Pharmaceutical Products and CMO Product Offered
11.3.3 Lonza Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Lonza Main Business Overview
11.3.5 Lonza Latest Developments
11.4 Piramal Healthcare
11.4.1 Piramal Healthcare Company Information
11.4.2 Piramal Healthcare Pharmaceutical Products and CMO Product Offered
11.4.3 Piramal Healthcare Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Piramal Healthcare Main Business Overview
11.4.5 Piramal Healthcare Latest Developments
11.5 Aenova
11.5.1 Aenova Company Information
11.5.2 Aenova Pharmaceutical Products and CMO Product Offered
11.5.3 Aenova Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Aenova Main Business Overview
11.5.5 Aenova Latest Developments
11.6 Jubilant
11.6.1 Jubilant Company Information
11.6.2 Jubilant Pharmaceutical Products and CMO Product Offered
11.6.3 Jubilant Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Jubilant Main Business Overview
11.6.5 Jubilant Latest Developments
11.7 Famar
11.7.1 Famar Company Information
11.7.2 Famar Pharmaceutical Products and CMO Product Offered
11.7.3 Famar Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Famar Main Business Overview
11.7.5 Famar Latest Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Information
11.8.2 Boehringer Ingelheim Pharmaceutical Products and CMO Product Offered
11.8.3 Boehringer Ingelheim Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Boehringer Ingelheim Main Business Overview
11.8.5 Boehringer Ingelheim Latest Developments
11.9 Fareva Holding
11.9.1 Fareva Holding Company Information
11.9.2 Fareva Holding Pharmaceutical Products and CMO Product Offered
11.9.3 Fareva Holding Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Fareva Holding Main Business Overview
11.9.5 Fareva Holding Latest Developments
11.10 AbbVie
11.10.1 AbbVie Company Information
11.10.2 AbbVie Pharmaceutical Products and CMO Product Offered
11.10.3 AbbVie Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 AbbVie Main Business Overview
11.10.5 AbbVie Latest Developments
11.11 Nipro Corp
11.11.1 Nipro Corp Company Information
11.11.2 Nipro Corp Pharmaceutical Products and CMO Product Offered
11.11.3 Nipro Corp Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Nipro Corp Main Business Overview
11.11.5 Nipro Corp Latest Developments
11.12 Vetter
11.12.1 Vetter Company Information
11.12.2 Vetter Pharmaceutical Products and CMO Product Offered
11.12.3 Vetter Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Vetter Main Business Overview
11.12.5 Vetter Latest Developments
11.13 Sopharma
11.13.1 Sopharma Company Information
11.13.2 Sopharma Pharmaceutical Products and CMO Product Offered
11.13.3 Sopharma Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Sopharma Main Business Overview
11.13.5 Sopharma Latest Developments
11.14 Mylan (DPT Laboratories)
11.14.1 Mylan (DPT Laboratories) Company Information
11.14.2 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Product Offered
11.14.3 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Mylan (DPT Laboratories) Main Business Overview
11.14.5 Mylan (DPT Laboratories) Latest Developments
11.15 Recipharm
11.15.1 Recipharm Company Information
11.15.2 Recipharm Pharmaceutical Products and CMO Product Offered
11.15.3 Recipharm Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Recipharm Main Business Overview
11.15.5 Recipharm Latest Developments
11.16 NextPharma Technologies
11.16.1 NextPharma Technologies Company Information
11.16.2 NextPharma Technologies Pharmaceutical Products and CMO Product Offered
11.16.3 NextPharma Technologies Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 NextPharma Technologies Main Business Overview
11.16.5 NextPharma Technologies Latest Developments
11.17 Dishman
11.17.1 Dishman Company Information
11.17.2 Dishman Pharmaceutical Products and CMO Product Offered
11.17.3 Dishman Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Dishman Main Business Overview
11.17.5 Dishman Latest Developments
11.18 Aesica
11.18.1 Aesica Company Information
11.18.2 Aesica Pharmaceutical Products and CMO Product Offered
11.18.3 Aesica Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Aesica Main Business Overview
11.18.5 Aesica Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical Products and CMO Market Size 2018-2029
2.1.2 Pharmaceutical Products and CMO Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Pharmaceutical Products and CMO Segment by Type
2.2.1 Active Pharmaceutical Ingredient (API)
2.2.2 Finished Dosage Form (FDF)
2.2.3 Pharmaceutical Packaging
2.3 Pharmaceutical Products and CMO Market Size by Type
2.3.1 Pharmaceutical Products and CMO Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Pharmaceutical Products and CMO Market Size Market Share by Type (2018-2023)
2.4 Pharmaceutical Products and CMO Segment by Application
2.4.1 Specialty/Midsize
2.4.2 Generics
2.4.3 Big Pharma
2.4.4 Others
2.5 Pharmaceutical Products and CMO Market Size by Application
2.5.1 Pharmaceutical Products and CMO Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Pharmaceutical Products and CMO Market Size Market Share by Application (2018-2023)
3 PHARMACEUTICAL PRODUCTS AND CMO MARKET SIZE BY PLAYER
3.1 Pharmaceutical Products and CMO Market Size Market Share by Players
3.1.1 Global Pharmaceutical Products and CMO Revenue by Players (2018-2023)
3.1.2 Global Pharmaceutical Products and CMO Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical Products and CMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL PRODUCTS AND CMO BY REGIONS
4.1 Pharmaceutical Products and CMO Market Size by Regions (2018-2023)
4.2 Americas Pharmaceutical Products and CMO Market Size Growth (2018-2023)
4.3 APAC Pharmaceutical Products and CMO Market Size Growth (2018-2023)
4.4 Europe Pharmaceutical Products and CMO Market Size Growth (2018-2023)
4.5 Middle East & Africa Pharmaceutical Products and CMO Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Pharmaceutical Products and CMO Market Size by Country (2018-2023)
5.2 Americas Pharmaceutical Products and CMO Market Size by Type (2018-2023)
5.3 Americas Pharmaceutical Products and CMO Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Products and CMO Market Size by Region (2018-2023)
6.2 APAC Pharmaceutical Products and CMO Market Size by Type (2018-2023)
6.3 APAC Pharmaceutical Products and CMO Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmaceutical Products and CMO by Country (2018-2023)
7.2 Europe Pharmaceutical Products and CMO Market Size by Type (2018-2023)
7.3 Europe Pharmaceutical Products and CMO Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical Products and CMO by Region (2018-2023)
8.2 Middle East & Africa Pharmaceutical Products and CMO Market Size by Type (2018-2023)
8.3 Middle East & Africa Pharmaceutical Products and CMO Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACEUTICAL PRODUCTS AND CMO MARKET FORECAST
10.1 Global Pharmaceutical Products and CMO Forecast by Regions (2024-2029)
10.1.1 Global Pharmaceutical Products and CMO Forecast by Regions (2024-2029)
10.1.2 Americas Pharmaceutical Products and CMO Forecast
10.1.3 APAC Pharmaceutical Products and CMO Forecast
10.1.4 Europe Pharmaceutical Products and CMO Forecast
10.1.5 Middle East & Africa Pharmaceutical Products and CMO Forecast
10.2 Americas Pharmaceutical Products and CMO Forecast by Country (2024-2029)
10.2.1 United States Pharmaceutical Products and CMO Market Forecast
10.2.2 Canada Pharmaceutical Products and CMO Market Forecast
10.2.3 Mexico Pharmaceutical Products and CMO Market Forecast
10.2.4 Brazil Pharmaceutical Products and CMO Market Forecast
10.3 APAC Pharmaceutical Products and CMO Forecast by Region (2024-2029)
10.3.1 China Pharmaceutical Products and CMO Market Forecast
10.3.2 Japan Pharmaceutical Products and CMO Market Forecast
10.3.3 Korea Pharmaceutical Products and CMO Market Forecast
10.3.4 Southeast Asia Pharmaceutical Products and CMO Market Forecast
10.3.5 India Pharmaceutical Products and CMO Market Forecast
10.3.6 Australia Pharmaceutical Products and CMO Market Forecast
10.4 Europe Pharmaceutical Products and CMO Forecast by Country (2024-2029)
10.4.1 Germany Pharmaceutical Products and CMO Market Forecast
10.4.2 France Pharmaceutical Products and CMO Market Forecast
10.4.3 UK Pharmaceutical Products and CMO Market Forecast
10.4.4 Italy Pharmaceutical Products and CMO Market Forecast
10.4.5 Russia Pharmaceutical Products and CMO Market Forecast
10.5 Middle East & Africa Pharmaceutical Products and CMO Forecast by Region (2024-2029)
10.5.1 Egypt Pharmaceutical Products and CMO Market Forecast
10.5.2 South Africa Pharmaceutical Products and CMO Market Forecast
10.5.3 Israel Pharmaceutical Products and CMO Market Forecast
10.5.4 Turkey Pharmaceutical Products and CMO Market Forecast
10.5.5 GCC Countries Pharmaceutical Products and CMO Market Forecast
10.6 Global Pharmaceutical Products and CMO Forecast by Type (2024-2029)
10.7 Global Pharmaceutical Products and CMO Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Catalent
11.1.1 Catalent Company Information
11.1.2 Catalent Pharmaceutical Products and CMO Product Offered
11.1.3 Catalent Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Catalent Main Business Overview
11.1.5 Catalent Latest Developments
11.2 DPx
11.2.1 DPx Company Information
11.2.2 DPx Pharmaceutical Products and CMO Product Offered
11.2.3 DPx Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 DPx Main Business Overview
11.2.5 DPx Latest Developments
11.3 Lonza
11.3.1 Lonza Company Information
11.3.2 Lonza Pharmaceutical Products and CMO Product Offered
11.3.3 Lonza Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Lonza Main Business Overview
11.3.5 Lonza Latest Developments
11.4 Piramal Healthcare
11.4.1 Piramal Healthcare Company Information
11.4.2 Piramal Healthcare Pharmaceutical Products and CMO Product Offered
11.4.3 Piramal Healthcare Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Piramal Healthcare Main Business Overview
11.4.5 Piramal Healthcare Latest Developments
11.5 Aenova
11.5.1 Aenova Company Information
11.5.2 Aenova Pharmaceutical Products and CMO Product Offered
11.5.3 Aenova Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Aenova Main Business Overview
11.5.5 Aenova Latest Developments
11.6 Jubilant
11.6.1 Jubilant Company Information
11.6.2 Jubilant Pharmaceutical Products and CMO Product Offered
11.6.3 Jubilant Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Jubilant Main Business Overview
11.6.5 Jubilant Latest Developments
11.7 Famar
11.7.1 Famar Company Information
11.7.2 Famar Pharmaceutical Products and CMO Product Offered
11.7.3 Famar Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Famar Main Business Overview
11.7.5 Famar Latest Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Information
11.8.2 Boehringer Ingelheim Pharmaceutical Products and CMO Product Offered
11.8.3 Boehringer Ingelheim Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Boehringer Ingelheim Main Business Overview
11.8.5 Boehringer Ingelheim Latest Developments
11.9 Fareva Holding
11.9.1 Fareva Holding Company Information
11.9.2 Fareva Holding Pharmaceutical Products and CMO Product Offered
11.9.3 Fareva Holding Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Fareva Holding Main Business Overview
11.9.5 Fareva Holding Latest Developments
11.10 AbbVie
11.10.1 AbbVie Company Information
11.10.2 AbbVie Pharmaceutical Products and CMO Product Offered
11.10.3 AbbVie Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 AbbVie Main Business Overview
11.10.5 AbbVie Latest Developments
11.11 Nipro Corp
11.11.1 Nipro Corp Company Information
11.11.2 Nipro Corp Pharmaceutical Products and CMO Product Offered
11.11.3 Nipro Corp Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Nipro Corp Main Business Overview
11.11.5 Nipro Corp Latest Developments
11.12 Vetter
11.12.1 Vetter Company Information
11.12.2 Vetter Pharmaceutical Products and CMO Product Offered
11.12.3 Vetter Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Vetter Main Business Overview
11.12.5 Vetter Latest Developments
11.13 Sopharma
11.13.1 Sopharma Company Information
11.13.2 Sopharma Pharmaceutical Products and CMO Product Offered
11.13.3 Sopharma Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Sopharma Main Business Overview
11.13.5 Sopharma Latest Developments
11.14 Mylan (DPT Laboratories)
11.14.1 Mylan (DPT Laboratories) Company Information
11.14.2 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Product Offered
11.14.3 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Mylan (DPT Laboratories) Main Business Overview
11.14.5 Mylan (DPT Laboratories) Latest Developments
11.15 Recipharm
11.15.1 Recipharm Company Information
11.15.2 Recipharm Pharmaceutical Products and CMO Product Offered
11.15.3 Recipharm Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Recipharm Main Business Overview
11.15.5 Recipharm Latest Developments
11.16 NextPharma Technologies
11.16.1 NextPharma Technologies Company Information
11.16.2 NextPharma Technologies Pharmaceutical Products and CMO Product Offered
11.16.3 NextPharma Technologies Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 NextPharma Technologies Main Business Overview
11.16.5 NextPharma Technologies Latest Developments
11.17 Dishman
11.17.1 Dishman Company Information
11.17.2 Dishman Pharmaceutical Products and CMO Product Offered
11.17.3 Dishman Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Dishman Main Business Overview
11.17.5 Dishman Latest Developments
11.18 Aesica
11.18.1 Aesica Company Information
11.18.2 Aesica Pharmaceutical Products and CMO Product Offered
11.18.3 Aesica Pharmaceutical Products and CMO Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Aesica Main Business Overview
11.18.5 Aesica Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pharmaceutical Products and CMO Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Active Pharmaceutical Ingredient (API)
Table 3. Major Players of Finished Dosage Form (FDF)
Table 4. Major Players of Pharmaceutical Packaging
Table 5. Pharmaceutical Products and CMO Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Pharmaceutical Products and CMO Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Pharmaceutical Products and CMO Market Size Market Share by Type (2018-2023)
Table 8. Pharmaceutical Products and CMO Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Pharmaceutical Products and CMO Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Pharmaceutical Products and CMO Market Size Market Share by Application (2018-2023)
Table 11. Global Pharmaceutical Products and CMO Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Pharmaceutical Products and CMO Revenue Market Share by Player (2018-2023)
Table 13. Pharmaceutical Products and CMO Key Players Head office and Products Offered
Table 14. Pharmaceutical Products and CMO Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Pharmaceutical Products and CMO Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Pharmaceutical Products and CMO Market Size Market Share by Regions (2018-2023)
Table 19. Global Pharmaceutical Products and CMO Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Pharmaceutical Products and CMO Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Pharmaceutical Products and CMO Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Pharmaceutical Products and CMO Market Size Market Share by Country (2018-2023)
Table 23. Americas Pharmaceutical Products and CMO Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Pharmaceutical Products and CMO Market Size Market Share by Type (2018-2023)
Table 25. Americas Pharmaceutical Products and CMO Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Pharmaceutical Products and CMO Market Size Market Share by Application (2018-2023)
Table 27. APAC Pharmaceutical Products and CMO Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Pharmaceutical Products and CMO Market Size Market Share by Region (2018-2023)
Table 29. APAC Pharmaceutical Products and CMO Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Pharmaceutical Products and CMO Market Size Market Share by Type (2018-2023)
Table 31. APAC Pharmaceutical Products and CMO Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Pharmaceutical Products and CMO Market Size Market Share by Application (2018-2023)
Table 33. Europe Pharmaceutical Products and CMO Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Pharmaceutical Products and CMO Market Size Market Share by Country (2018-2023)
Table 35. Europe Pharmaceutical Products and CMO Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Pharmaceutical Products and CMO Market Size Market Share by Type (2018-2023)
Table 37. Europe Pharmaceutical Products and CMO Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Pharmaceutical Products and CMO Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Pharmaceutical Products and CMO Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Pharmaceutical Products and CMO Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Pharmaceutical Products and CMO Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Pharmaceutical Products and CMO Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Pharmaceutical Products and CMO Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Pharmaceutical Products and CMO Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Pharmaceutical Products and CMO
Table 46. Key Market Challenges & Risks of Pharmaceutical Products and CMO
Table 47. Key Industry Trends of Pharmaceutical Products and CMO
Table 48. Global Pharmaceutical Products and CMO Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Pharmaceutical Products and CMO Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Pharmaceutical Products and CMO Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Pharmaceutical Products and CMO Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Catalent Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 53. Catalent Pharmaceutical Products and CMO Product Offered
Table 54. Catalent Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Catalent Main Business
Table 56. Catalent Latest Developments
Table 57. DPx Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 58. DPx Pharmaceutical Products and CMO Product Offered
Table 59. DPx Main Business
Table 60. DPx Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. DPx Latest Developments
Table 62. Lonza Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 63. Lonza Pharmaceutical Products and CMO Product Offered
Table 64. Lonza Main Business
Table 65. Lonza Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Lonza Latest Developments
Table 67. Piramal Healthcare Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 68. Piramal Healthcare Pharmaceutical Products and CMO Product Offered
Table 69. Piramal Healthcare Main Business
Table 70. Piramal Healthcare Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Piramal Healthcare Latest Developments
Table 72. Aenova Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 73. Aenova Pharmaceutical Products and CMO Product Offered
Table 74. Aenova Main Business
Table 75. Aenova Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Aenova Latest Developments
Table 77. Jubilant Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 78. Jubilant Pharmaceutical Products and CMO Product Offered
Table 79. Jubilant Main Business
Table 80. Jubilant Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Jubilant Latest Developments
Table 82. Famar Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 83. Famar Pharmaceutical Products and CMO Product Offered
Table 84. Famar Main Business
Table 85. Famar Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Famar Latest Developments
Table 87. Boehringer Ingelheim Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 88. Boehringer Ingelheim Pharmaceutical Products and CMO Product Offered
Table 89. Boehringer Ingelheim Main Business
Table 90. Boehringer Ingelheim Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Boehringer Ingelheim Latest Developments
Table 92. Fareva Holding Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 93. Fareva Holding Pharmaceutical Products and CMO Product Offered
Table 94. Fareva Holding Main Business
Table 95. Fareva Holding Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Fareva Holding Latest Developments
Table 97. AbbVie Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 98. AbbVie Pharmaceutical Products and CMO Product Offered
Table 99. AbbVie Main Business
Table 100. AbbVie Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. AbbVie Latest Developments
Table 102. Nipro Corp Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 103. Nipro Corp Pharmaceutical Products and CMO Product Offered
Table 104. Nipro Corp Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Nipro Corp Main Business
Table 106. Nipro Corp Latest Developments
Table 107. Vetter Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 108. Vetter Pharmaceutical Products and CMO Product Offered
Table 109. Vetter Main Business
Table 110. Vetter Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Vetter Latest Developments
Table 112. Sopharma Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 113. Sopharma Pharmaceutical Products and CMO Product Offered
Table 114. Sopharma Main Business
Table 115. Sopharma Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Sopharma Latest Developments
Table 117. Mylan (DPT Laboratories) Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 118. Mylan (DPT Laboratories) Pharmaceutical Products and CMO Product Offered
Table 119. Mylan (DPT Laboratories) Main Business
Table 120. Mylan (DPT Laboratories) Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Mylan (DPT Laboratories) Latest Developments
Table 122. Recipharm Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 123. Recipharm Pharmaceutical Products and CMO Product Offered
Table 124. Recipharm Main Business
Table 125. Recipharm Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Recipharm Latest Developments
Table 127. NextPharma Technologies Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 128. NextPharma Technologies Pharmaceutical Products and CMO Product Offered
Table 129. NextPharma Technologies Main Business
Table 130. NextPharma Technologies Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. NextPharma Technologies Latest Developments
Table 132. Dishman Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 133. Dishman Pharmaceutical Products and CMO Product Offered
Table 134. Dishman Main Business
Table 135. Dishman Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Dishman Latest Developments
Table 137. Aesica Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 138. Aesica Pharmaceutical Products and CMO Product Offered
Table 139. Aesica Main Business
Table 140. Aesica Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Aesica Latest Developments
Table 1. Pharmaceutical Products and CMO Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Active Pharmaceutical Ingredient (API)
Table 3. Major Players of Finished Dosage Form (FDF)
Table 4. Major Players of Pharmaceutical Packaging
Table 5. Pharmaceutical Products and CMO Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Pharmaceutical Products and CMO Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Pharmaceutical Products and CMO Market Size Market Share by Type (2018-2023)
Table 8. Pharmaceutical Products and CMO Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Pharmaceutical Products and CMO Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Pharmaceutical Products and CMO Market Size Market Share by Application (2018-2023)
Table 11. Global Pharmaceutical Products and CMO Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Pharmaceutical Products and CMO Revenue Market Share by Player (2018-2023)
Table 13. Pharmaceutical Products and CMO Key Players Head office and Products Offered
Table 14. Pharmaceutical Products and CMO Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Pharmaceutical Products and CMO Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Pharmaceutical Products and CMO Market Size Market Share by Regions (2018-2023)
Table 19. Global Pharmaceutical Products and CMO Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Pharmaceutical Products and CMO Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Pharmaceutical Products and CMO Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Pharmaceutical Products and CMO Market Size Market Share by Country (2018-2023)
Table 23. Americas Pharmaceutical Products and CMO Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Pharmaceutical Products and CMO Market Size Market Share by Type (2018-2023)
Table 25. Americas Pharmaceutical Products and CMO Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Pharmaceutical Products and CMO Market Size Market Share by Application (2018-2023)
Table 27. APAC Pharmaceutical Products and CMO Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Pharmaceutical Products and CMO Market Size Market Share by Region (2018-2023)
Table 29. APAC Pharmaceutical Products and CMO Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Pharmaceutical Products and CMO Market Size Market Share by Type (2018-2023)
Table 31. APAC Pharmaceutical Products and CMO Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Pharmaceutical Products and CMO Market Size Market Share by Application (2018-2023)
Table 33. Europe Pharmaceutical Products and CMO Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Pharmaceutical Products and CMO Market Size Market Share by Country (2018-2023)
Table 35. Europe Pharmaceutical Products and CMO Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Pharmaceutical Products and CMO Market Size Market Share by Type (2018-2023)
Table 37. Europe Pharmaceutical Products and CMO Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Pharmaceutical Products and CMO Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Pharmaceutical Products and CMO Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Pharmaceutical Products and CMO Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Pharmaceutical Products and CMO Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Pharmaceutical Products and CMO Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Pharmaceutical Products and CMO Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Pharmaceutical Products and CMO Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Pharmaceutical Products and CMO
Table 46. Key Market Challenges & Risks of Pharmaceutical Products and CMO
Table 47. Key Industry Trends of Pharmaceutical Products and CMO
Table 48. Global Pharmaceutical Products and CMO Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Pharmaceutical Products and CMO Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Pharmaceutical Products and CMO Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Pharmaceutical Products and CMO Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Catalent Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 53. Catalent Pharmaceutical Products and CMO Product Offered
Table 54. Catalent Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Catalent Main Business
Table 56. Catalent Latest Developments
Table 57. DPx Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 58. DPx Pharmaceutical Products and CMO Product Offered
Table 59. DPx Main Business
Table 60. DPx Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. DPx Latest Developments
Table 62. Lonza Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 63. Lonza Pharmaceutical Products and CMO Product Offered
Table 64. Lonza Main Business
Table 65. Lonza Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Lonza Latest Developments
Table 67. Piramal Healthcare Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 68. Piramal Healthcare Pharmaceutical Products and CMO Product Offered
Table 69. Piramal Healthcare Main Business
Table 70. Piramal Healthcare Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Piramal Healthcare Latest Developments
Table 72. Aenova Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 73. Aenova Pharmaceutical Products and CMO Product Offered
Table 74. Aenova Main Business
Table 75. Aenova Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Aenova Latest Developments
Table 77. Jubilant Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 78. Jubilant Pharmaceutical Products and CMO Product Offered
Table 79. Jubilant Main Business
Table 80. Jubilant Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Jubilant Latest Developments
Table 82. Famar Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 83. Famar Pharmaceutical Products and CMO Product Offered
Table 84. Famar Main Business
Table 85. Famar Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Famar Latest Developments
Table 87. Boehringer Ingelheim Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 88. Boehringer Ingelheim Pharmaceutical Products and CMO Product Offered
Table 89. Boehringer Ingelheim Main Business
Table 90. Boehringer Ingelheim Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Boehringer Ingelheim Latest Developments
Table 92. Fareva Holding Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 93. Fareva Holding Pharmaceutical Products and CMO Product Offered
Table 94. Fareva Holding Main Business
Table 95. Fareva Holding Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Fareva Holding Latest Developments
Table 97. AbbVie Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 98. AbbVie Pharmaceutical Products and CMO Product Offered
Table 99. AbbVie Main Business
Table 100. AbbVie Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. AbbVie Latest Developments
Table 102. Nipro Corp Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 103. Nipro Corp Pharmaceutical Products and CMO Product Offered
Table 104. Nipro Corp Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Nipro Corp Main Business
Table 106. Nipro Corp Latest Developments
Table 107. Vetter Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 108. Vetter Pharmaceutical Products and CMO Product Offered
Table 109. Vetter Main Business
Table 110. Vetter Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Vetter Latest Developments
Table 112. Sopharma Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 113. Sopharma Pharmaceutical Products and CMO Product Offered
Table 114. Sopharma Main Business
Table 115. Sopharma Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Sopharma Latest Developments
Table 117. Mylan (DPT Laboratories) Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 118. Mylan (DPT Laboratories) Pharmaceutical Products and CMO Product Offered
Table 119. Mylan (DPT Laboratories) Main Business
Table 120. Mylan (DPT Laboratories) Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Mylan (DPT Laboratories) Latest Developments
Table 122. Recipharm Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 123. Recipharm Pharmaceutical Products and CMO Product Offered
Table 124. Recipharm Main Business
Table 125. Recipharm Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Recipharm Latest Developments
Table 127. NextPharma Technologies Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 128. NextPharma Technologies Pharmaceutical Products and CMO Product Offered
Table 129. NextPharma Technologies Main Business
Table 130. NextPharma Technologies Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. NextPharma Technologies Latest Developments
Table 132. Dishman Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 133. Dishman Pharmaceutical Products and CMO Product Offered
Table 134. Dishman Main Business
Table 135. Dishman Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Dishman Latest Developments
Table 137. Aesica Details, Company Type, Pharmaceutical Products and CMO Area Served and Its Competitors
Table 138. Aesica Pharmaceutical Products and CMO Product Offered
Table 139. Aesica Main Business
Table 140. Aesica Pharmaceutical Products and CMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Aesica Latest Developments
LIST OF FIGURES
Figure 1. Pharmaceutical Products and CMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical Products and CMO Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Pharmaceutical Products and CMO Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Pharmaceutical Products and CMO Sales Market Share by Country/Region (2022)
Figure 8. Pharmaceutical Products and CMO Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Pharmaceutical Products and CMO Market Size Market Share by Type in 2022
Figure 10. Pharmaceutical Products and CMO in Specialty/Midsize
Figure 11. Global Pharmaceutical Products and CMO Market: Specialty/Midsize (2018-2023) & ($ Millions)
Figure 12. Pharmaceutical Products and CMO in Generics
Figure 13. Global Pharmaceutical Products and CMO Market: Generics (2018-2023) & ($ Millions)
Figure 14. Pharmaceutical Products and CMO in Big Pharma
Figure 15. Global Pharmaceutical Products and CMO Market: Big Pharma (2018-2023) & ($ Millions)
Figure 16. Pharmaceutical Products and CMO in Others
Figure 17. Global Pharmaceutical Products and CMO Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Pharmaceutical Products and CMO Market Size Market Share by Application in 2022
Figure 19. Global Pharmaceutical Products and CMO Revenue Market Share by Player in 2022
Figure 20. Global Pharmaceutical Products and CMO Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Pharmaceutical Products and CMO Market Size 2018-2023 ($ Millions)
Figure 22. APAC Pharmaceutical Products and CMO Market Size 2018-2023 ($ Millions)
Figure 23. Europe Pharmaceutical Products and CMO Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Pharmaceutical Products and CMO Market Size 2018-2023 ($ Millions)
Figure 25. Americas Pharmaceutical Products and CMO Value Market Share by Country in 2022
Figure 26. United States Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Pharmaceutical Products and CMO Market Size Market Share by Region in 2022
Figure 31. APAC Pharmaceutical Products and CMO Market Size Market Share by Type in 2022
Figure 32. APAC Pharmaceutical Products and CMO Market Size Market Share by Application in 2022
Figure 33. China Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Pharmaceutical Products and CMO Market Size Market Share by Country in 2022
Figure 40. Europe Pharmaceutical Products and CMO Market Size Market Share by Type (2018-2023)
Figure 41. Europe Pharmaceutical Products and CMO Market Size Market Share by Application (2018-2023)
Figure 42. Germany Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Pharmaceutical Products and CMO Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Pharmaceutical Products and CMO Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Pharmaceutical Products and CMO Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 56. APAC Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 57. Europe Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 59. United States Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 60. Canada Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 63. China Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 64. Japan Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 65. Korea Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 67. India Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 68. Australia Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 69. Germany Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 70. France Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 71. UK Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 72. Italy Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 73. Russia Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 74. Spain Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 77. Israel Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 80. Global Pharmaceutical Products and CMO Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Pharmaceutical Products and CMO Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Pharmaceutical Products and CMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical Products and CMO Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Pharmaceutical Products and CMO Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Pharmaceutical Products and CMO Sales Market Share by Country/Region (2022)
Figure 8. Pharmaceutical Products and CMO Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Pharmaceutical Products and CMO Market Size Market Share by Type in 2022
Figure 10. Pharmaceutical Products and CMO in Specialty/Midsize
Figure 11. Global Pharmaceutical Products and CMO Market: Specialty/Midsize (2018-2023) & ($ Millions)
Figure 12. Pharmaceutical Products and CMO in Generics
Figure 13. Global Pharmaceutical Products and CMO Market: Generics (2018-2023) & ($ Millions)
Figure 14. Pharmaceutical Products and CMO in Big Pharma
Figure 15. Global Pharmaceutical Products and CMO Market: Big Pharma (2018-2023) & ($ Millions)
Figure 16. Pharmaceutical Products and CMO in Others
Figure 17. Global Pharmaceutical Products and CMO Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Pharmaceutical Products and CMO Market Size Market Share by Application in 2022
Figure 19. Global Pharmaceutical Products and CMO Revenue Market Share by Player in 2022
Figure 20. Global Pharmaceutical Products and CMO Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Pharmaceutical Products and CMO Market Size 2018-2023 ($ Millions)
Figure 22. APAC Pharmaceutical Products and CMO Market Size 2018-2023 ($ Millions)
Figure 23. Europe Pharmaceutical Products and CMO Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Pharmaceutical Products and CMO Market Size 2018-2023 ($ Millions)
Figure 25. Americas Pharmaceutical Products and CMO Value Market Share by Country in 2022
Figure 26. United States Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Pharmaceutical Products and CMO Market Size Market Share by Region in 2022
Figure 31. APAC Pharmaceutical Products and CMO Market Size Market Share by Type in 2022
Figure 32. APAC Pharmaceutical Products and CMO Market Size Market Share by Application in 2022
Figure 33. China Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Pharmaceutical Products and CMO Market Size Market Share by Country in 2022
Figure 40. Europe Pharmaceutical Products and CMO Market Size Market Share by Type (2018-2023)
Figure 41. Europe Pharmaceutical Products and CMO Market Size Market Share by Application (2018-2023)
Figure 42. Germany Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Pharmaceutical Products and CMO Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Pharmaceutical Products and CMO Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Pharmaceutical Products and CMO Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Pharmaceutical Products and CMO Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 56. APAC Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 57. Europe Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 59. United States Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 60. Canada Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 63. China Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 64. Japan Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 65. Korea Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 67. India Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 68. Australia Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 69. Germany Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 70. France Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 71. UK Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 72. Italy Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 73. Russia Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 74. Spain Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 77. Israel Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Pharmaceutical Products and CMO Market Size 2024-2029 ($ Millions)
Figure 80. Global Pharmaceutical Products and CMO Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Pharmaceutical Products and CMO Market Size Market Share Forecast by Application (2024-2029)
